Table 2.
AEDs | Therapeutic range | Pharmacokinetics parameters | ||
---|---|---|---|---|
Narrow therapeutic range | Low water solubility | Nonlinear pharmacokinetics | ||
Carbamazepine | 4–12 μg/ml | Yes | Yes | Yes |
Phenytoin | 10–20 μg/ml | Yes | Yes | Yes |
Valproate | 50–100 μg/ml | Yes | No | Yes |
Phenobarbital | 20–40 μg/ml | Yes | No | No |
Ethosuximide | 40–100 μg/ml | Yes | No | Yes |
Gabapentin | 4–20 μg/ml | Yes | No | Yes |
Lamotrigine | 4–20 μg/ml | No | Yes | No |
Levetiracetam | 5–40 μg/ml | Yes | No | No |
Oxcarbazepine | 10–40 μg/ml | Yes | Yes | No |
Topiramate | 10–20 μg/ml | Yes | Yes | No |
Tiagibine | 100–300 ng/ml | Yes | No | No |
Vigabatrin | 0.8–36 μg/ml | Yes | No | No |
Primidone | 5–10 μg/ml | Yes | Yes | No |
Felbamate | 30–100 μg/ml | Yes | Yes | No |
Zonisamide | 10–40 μg/ml | Yes | Yes | Yes |